Deerpath Capital Management, a private credit manager focused on lending to the U.S. lower-middle market, reset and upsized Deerpath CLO 2018-1, a $402.8 million collateralized loan obligation (CLO).
Deerpath Capital Management closed Deerpath CLO 2024-1, a $452.6 million collateralized loan obligation (CLO). This marks Deerpath’s first new issuance CLO in 2024. Including a CLO reset and upsize in July 2023 and CLO 2023-2, this transaction represents the firm’s 10th CLO over the past six years.
Deerpath Capital Management, a provider of cash-flow based senior debt financing to lower middle-market companies across North America, opened its latest international office in Tokyo. The Tokyo office will be led by Taichiro “Tai” Watanabe, who joined Deerpath as senior vice president and the first Japan-based member of Deerpath’s investor partnerships team.
Deerpath Capital Management closed Deerpath CLO 2023-2, a $353.65 million collateralized loan obligation, marking Deerpath’s second new issuance CLO in 2023 and, including a CLO reset and upsize in July, the firm’s ninth CLO over the past six years.
Kelvin Group acquired Advanced Examination Services, a provider of non-destructive testing services for the petroleum, chemical and agricultural industries. Deerpath Capital Management provided debt financing to support the transaction.
Deerpath Capital Management launched its newest international office in London. The office, located in Berkeley Square, will serve as Deerpath’s European headquarters and will be led by private markets specialist Tania Kutner as head of European investor partnerships.
Deerpath Capital Management closed Deerpath CLO 2022-1, a $375 million collateralized loan obligation (CLO). Deerpath CLO 2022-1 represents the fifth CLO issued by Deerpath since 2018 and brings the firm’s total CLO assets under management to approximately $1.8 billion.
The Kelvin Group completed the acquisition of Refrigeration Design & Service. Deerpath Capital Management provided debt financing.
Deerpath Capital Management, a provider of cash flow-based senior debt financing to lower middle-market companies in North America, closed Deerpath CLO 2021-2, a $425 million collateralized loan obligation.
Sheridan Capital Partners invested in DAS Health Ventures, a provider of healthcare IT management solutions and services. Deerpath Capital Management provided debt financing for the transaction.